MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

BIIB — Biogen Inc. Common Stock

Nasdaq

Biogen Inc. Common Stock

CompareBack to Screener
$219.88
-2.94(-1.32%)
O
222.98
H
224.08
L
219.81
V
765.7K
⏱️ End-of-day dataAs of Oct 2, 2026

Biogen Inc. Common Stock Statistics

Total Valuation

Market Cap$33.63B
Enterprise Value$33.95B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding147.75M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio102.27
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio17.42
P/TBV Ration/a
P/FCF Ratio601.27
P/OCF Ratio370.48
PEG Ration/a

Enterprise Valuation

EV / Earnings1,062.50
EV / Salesn/a
EV / EBITDA484.26
EV / EBIT762.33
EV / FCF606.95

Financial Position

Current Ratio3.06
Quick Ration/a
Debt / Equity0.35
Debt / EBITDA9.36
Debt / FCF11.73
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)1.71%
Return on Assets (ROA)1.08%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$4,260
Employee Count7,500
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$58.20M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change+41.63%
50-Day Moving Average$215.29
200-Day Moving Average$195.19
Relative Strength Index (RSI)53.90
Average Volume (20 Days)1,069,538

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$181.68M
Operating Income$45.98M
Pretax Income$37.77M
Net Income$31.95M
EBITDA$70.10M
EBIT$44.53M
Earnings Per Share$2.15

Balance Sheet

Cash & Cash Equivalents$338.27M
Total Debt$656.19M
Net Cash-$317.92M
Net Cash Per Share$-2.15
Equity (Book Value)$1.87B
Book Value Per Share$12.62
Working Capital$619.15M

Cash Flow

Operating Cash Flow$90.77M
Capital Expenditures-$51.20M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$55.93M
FCF Per Share$0.38

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield0.98%
FCF Yield0.17%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$32.25
Lynch Upside-85.33%
Graham Number$24.71
Graham Upside-88.76%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a